Reduced neuronal co-localisation of nardilysin and the putative α-secretases ADAM10 and ADAM17 in Alzheimer's disease and Down syndrome brains

Age

Volumn 31, Issue 1, 2009, Pages 11-25

  Bernstein, Hans Gert ^a   Stricker, Rolf ^a   Lendeckel, Uwe ^a   Bertram, Iris ^a   Dobrowolny, Henrik ^a   Steiner, Johann ^a   Bogerts, Bernhard ^a   Reiser, Georg ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

Alzheimer's disease; Down syndrome; Human cerebral cortex; Immunohistochemistry; Metalloprotease

Indexed keywords

EID: 60849126393     PISSN: 01619152     EISSN: 15744647     Source Type: Journal    
DOI: 10.1007/s11357-008-9076-x     Document Type: Article

References (54)

1. IP4, a high-affinity inositol(1,3,4,5)tetrakisphosphate/ phosphatidylinositol(3,4,5)trisphosphate binding protein Biochim Biophys Acta 1387 117 128
2. U Arvidsson M Riedl R Elde 1997 Vesicular acetylcholine transporter (VAChT) protein: a novel and unique marker for cholinergic neurons in the central and peripheral nervous systems J Comp Neurol 378 454 467
3. S Bandyopadhyay LE Goldstein DK Lahiri 2007 Role of the APP non-amyloidogenic signaling pathway and targeting alpha-secretase as an alternative drug target for treatment of Alzheimer's disease Curr Med Chem 14 2848 2864
4. D Bataille G Fontés S Costes 2006 The glucagon-miniglucagon interplay: a new level in the metabolic regulation Ann N Y Acad Sci 1070 161 166
5. MF Beal NW Kowall MF Mazurek 1987 Neuropeptides in Alzheimer's disease J Neural Transm Suppl 24 163 174
6. KF Bell L Zheng F Fahrenholz 2008 ADAM-10 over-expression increases cortical synaptogenesis Neurobiol Aging 29 554 565
7. HG Bernstein E Schon S Ansorge I Rose A Dorn 1987 Immunolocalization of dipeptidyl aminopeptidase (DAP IV) in the developing human brain Int J Dev Neurosci 5 237 242
8. HG Bernstein H Kirschke B Wiederanders 1996 The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review Mol Chem Neuropathol 27 225 247
9. HG Bernstein A Stanarius B Baumann 1998 Nitric oxide synthase-containing neurons in the human hypothalamus: reduced number of immunoreactive cells in the paraventricular nucleus of depressive patients and schizophrenics Neuroscience 83 867 875
10. HG Bernstein B Baumann P Danos 1999 Regional and cellular distribution of neural visinin-like protein immunoreactivities (VILIP-1 and VILIP-3) in human brain J Neurocytol 28 655 662
11. HG Bernstein A Bukowska D Krell 2003 Comparative localization of ADAMs 10 and 15 in human cerebral cortex normal aging, Alzheimer disease and Down syndrome J Neurocytol 32 153 160
12. HG Bernstein R Stricker H Dobrowolny 2007 Histochemical evidence for wide expression of the metalloendopeptidase nardilysin in human brain neurons Neuroscience 146 1513 1523
13. K Braunewell P Riederer C Spilker 2001 Abnormal localization of two neuronal calcium sensor proteins, visinin-like proteins (vilips)-1 and -3, in neocortical brain areas of Alzheimer disease patients Dement Geriatr Cogn Disord 12 110 116
14. P Bubber V Haroutunian G Fisch 2005 Mitochondrial abnormalities in Alzheimer brain: mechanistic implications Ann Neurol 57 695 703
15. F Cataldo L Scola M Piccione 2005 Evaluation of cytokine polymorphisms (TNFalpha, IFNgamma and IL-10) in Down patients with coeliac disease Dig Liver Dis 37 923 927
16. V Chesneau AR Pierotti N Barre 1994 Isolation and characterization of a dibasic selective metalloendopeptidase from rat testes that cleaves at the amino terminus of arginine residues J Biol Chem 269 2056 2061
17. KM Chow O Oakley J Goodman 2003 Nardilysin cleaves peptides at monobasic sites Biochemistry 42 2239 2244
18. Chow KM, Ma Z, Cai J et al (2005) Nardilysin facilitates complex formation between mitochondrial malate dehydrogenase and citrate synthase. Biochim Biophys Acta 1723:292-301
19. E Csuhai G Chen LB Hersh 1998 Regulation of N-arginine dibasic convertase activity by amines: putative role of a novel acidic domain as an amine binding site Biochemistry 37 3787 3794
20. M Deuss K Reiss D Hartmann 2008 Part-time alpha-secretases: the functional biology of ADAM 9, 10 and 17 Curr Alzheimer Res 5 187 201
21. P Dournaud P Delaere JJ Hauw 1995 Differential correlation between neurochemical deficits, neuropathology, and cognitive status in Alzheimer's disease Neurobiol Aging 16 817 823
22. F Fahrenholz 2007 Alpha-secretase as a therapeutic target Curr Alzheimer Res 4 412 417
23. Y Hiraoka M Ohno K Yoshida 2007 Enhancement of alpha-secretase cleavage of amyloid precursor protein by a metalloendopeptidase nardilysin J Neurochem 102 1595 1605
24. Y Hiraoka K Yoshida M Ohno 2008 Ectodomain shedding of TNF-alpha is enhanced by nardilysin via activation of ADAM proteases Biochem Biophys Res Commun 370 154 158
25. NM Hooper 1994 Families of zinc metalloproteases FEBS Lett 354 1 6
26. V Hospital V Chesneau A Balogh 2000 N-arginine dibasic convertase (nardilysin) isoforms are soluble dibasic-specific metalloendopeptidases that localize in the cytoplasm and at the cell surface Biochem J 349 587 597
27. K Jin XO Mao Y Sun 2002 Heparin-binding epidermal growth factor-like growth factor: hypoxia-inducible expression in vitro and stimulation of neurogenesis in vitro and in vivo J Neurosci 22 5365 5373
28. K Jin AL Peel XO Mao 2004 Increased hippocampal neurogenesis in Alzheimer's disease Proc Natl Acad Sci USA 101 343 347
29. BC Kieseier H Pischel E Neuen-Jacob 2003 ADAM-10 and ADAM-17 in the inflamed human CNS Glia 42 398 405
30. IT Lott E Head E Doran 2006 Beta-amyloid, oxidative stress and down syndrome Curr Alzheimer Res 3 521 528
31. OC Maes S Xu B Yu 2007 Transcriptional profiling of Alzheimer blood mononuclear cells by microarray Neurobiol Aging 28 1795 1809
32. M Marcinkiewicz NG Seidah 2000 Coordinated expression of beta-amyloid precursor protein and the putative beta-secretase BACE and alpha-secretase ADAM10 in mouse and human brain J Neurochem 75 2133 2143
33. MM Mouradian J Blin M Giuffra 1991 Somatostatin replacement therapy for Alzheimer dementia Ann Neurol 30 610 613
34. M Murphy DS Friend L Pike-Nobile 1992 Tumor necrosis factor-alpha and IFN-gamma expression in human thymus. Localization and overexpression in Down syndrome (trisomy 21) J Immunol 149 2506 2512
35. M Murphy W Hyun B Hunte 1992 A role for tumor necrosis factor-alpha and interferon-gamma in the regulation of interleukin-4-induced human thymocyte proliferation in vitro. Heightened sensitivity in the Down syndrome (trisomy 21) thymus Pediatr Res 32 269 276
36. M Murphy RM Insoft L Pike-Nobile 1995 A hypothesis to explain the immune defects in Down syndrome Prog Clin Biol Res 393 147 167
37. E Nishi A Prat V Hospital 2001 N-arginine dibasic convertase is a specific receptor for heparin-binding EGF-like growth factor that mediates cell migration EMBO J 20 3342 3350
38. E Nishi Y Hiraoka K Yoshida 2006 Nardilysin enhances ectodomain shedding of heparin-binding epidermal growth factor-like growth factor through activation of tumor necrosis factor-alpha-converting enzyme J Biol Chem 281 31164 31172
39. M Nistor M Don M Parekh 2007 Alpha- and beta-secretase activity as a function of age and beta-amyloid in Down syndrome and normal brain Neurobiol Aging 28 1493 1506
40. AR Pierotti A Prat V Chesneau 1994 N-arginine dibasic convertase, a metalloendopeptidase as a prototype of a class of processing enzymes Proc Natl Acad Sci USA 91 6078 6082
41. ND Rawlings AJ Barrett 1993 Evolutionary families of peptidases Biochem J 290 205 218
42. IP4/centaurin α Neuroreport 13 2417 2419
43. IP4 with nucleolin Neuroreport 15 147 148
44. MN Rossor LL Iversen GP Reynolds 1984 Neurochemical characteristics of early and late onset types of Alzheimer's disease Br Med J (Clin Res Ed) 288 961 964
45. LD Selemon J Mrzljak JE Kleinman 2003 Regional specificity in the neuropathologic substrates of schizophrenia: a morphometric analysis of Broca's area 44 and area 9 Arch Gen Psychiatry 60 69 77
46. DM Skovronsky S Fath VM Lee 2001 Neuronal localization of the TNFalpha converting enzyme (TACE) in brain tissue and its correlation to amyloid plaques J Neurobiol 49 40 46
47. DM Skovronsky VM Lee JQ Trojanowski 2006 Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications Annu Rev Pathol 1 151 170
48. M Spiechowicz HG Bernstein H Dobrowolny 2006 Density of Sgt1-immunopositive neurons is decreased in the cerebral cortex of Alzheimer's disease brain Neurochem Int 49 487 493
49. 3 FEBS Lett 405 229 236
50. 4, with stereospecificity J Neurochem 98 343 354
51. R Winsky-Sommerer D Grouselle C Rougeot 2003 The proprotein convertase PC2 is involved in the maturation of prosomatostatin to somatostatin-14 but not in the somatostatin deficit in Alzheimer's disease Neuroscience 122 437 447
52. T Yakovleva Z Marinova A Kuzmin 2007 Dysregulation of dynorphins in Alzheimer disease Neurobiol Aging 28 1700 1708
53. P Yang KA Baker T Hagg 2006 The ADAMs family: coordinators of nervous system development, plasticity and repair Prog Neurobiol 79 73 94
54. HQ Yang J Pan MW Ba 2007 New protein kinase C activator regulates amyloid precursor protein processing in vitro by increasing alpha-secretase activity Eur J Neurosci 26 381 391